Isocyanates are a group of highly reactive organic compounds used in the manufacture of:

• adhesives and glues
• coatings lacquers and varnishes
• spray paints
• elastomers and foams
• floor / roof screeding
• hardwearing plastics
• medical dressings

Isocyanates are toxic until they react with other chemicals to form the hardened or ‘cured ‘polyurethane product. Fully-cured polyurethanes are non-toxic, unless they are heated or abraded, which makes them give off isocyanates and other toxic substances.

Isocyanate exposure is associated with numerous health problems. Exposure can cause asthma, skin sensitisation, skin or mucous membrane irritation, and, rarely, a lung reaction called hypersensitivity pneumonitis.

Occupational Asthma

They are one of the leading causes of occupational asthma in Australia. The condition commonly presents as:

• wheezing
• chest tightness and shortness of breath
• cough

The symptoms can occur at work, or much later after work, and the asthma can be made much worse by repeated exposure.

Once a worker has been sensitised, even very low-level exposures might produce a potentially life-threatening asthma attack, which may end their career. Exposure to isocyanate aerosols can lead to hypersensitisation which can give rise to ‘bagpipe lung’ (also known as extrinsic allergic alveolitis or hypersensitivity pneumonitis).

Skin Sensitisation

Sensitisation by skin contact can cause allergies that can affect both the skin and/or the lungs. Acute exposure to these chemicals can cause irritation to the eyes, skin, and mucous membranes of the nose and the throat, occasionally accompanied by headaches and itching. Sensitisation can occur at isocyanate concentrations lower than those that may give rise to irritation.

Potentially Cancer-Causing

Most isocyanates are not carcinogens – the exception is TDI (toluene diisocyanate) which has been found to cause cancer in some laboratory animals (although it has never actually been demonstrated in humans). Isocyanates are not associated with human fertility or pregnancy problems nor with abnormalities of foetal development.

To safeguard workers’ health and minimise the risks associated with exposure, control measures and biological monitoring programs are essential.

Control Measures

Since isocyanates can act as skin and respiratory sensitisers, and to control the risk of future health issues in the workplace, exposure to isocyanates should be kept as low as reasonably practicable.

If adequate control measures are in place – such as closed ventilation systems (spray booths, enclosed moulding machines), air-fed respiratory protection and personal protective clothing/gloves – these conditions, and episodes of isocyanate exposure, are easily preventable.

Biological Monitoring Program

Isocyanate Biological Monitoring (BM) is especially necessary for workers involved with:

• motor vehicle repair paint use
• foam blowing
• hard polyurethane manufacture
• glues and adhesives
• floor screeding
• underground mining.

BM is a simple and cost-effective way to check that workplace control measures are sufficient, being effectively applied and exposure is being adequately controlled.

BM assesses worker exposure to isocyanates, confirms control measures, and prevents health risks. While not a diagnostic tool for isocyanate-related conditions, it helps identify occupational exposure when symptoms arise. BM also gauges skin absorption, especially with glove use. It’s user-friendly, providing personalised results to promote better work habits.

BM aggregates all routes of exposure, inhalation, skin absorption and ingestion, so a result cannot identify the actual source/route of exposure. It will, however, show the need for corrective action to be taken.

Safe Work Australia’s Guidelines for Isocyanate Exposure Monitoring

Safe Work Australia recommends that Biological Monitoring programs for workers using or exposed to isocyanates should include:

• Initial baseline BM upon the commencing employment
• Periodic BM review, generally performed after 6 weeks of commencement (of isocyanate exposure)
• Regular 6-monthly BM every six months. If after 12 months, no adverse health issues are reported this should then switch to annual testing
• Terminal BM performed at the end/termination of the period of isocyanate exposure.

How Is Isocyanate Exposure Testing Performed?

A post-exposure urine sample should be taken, ideally within an hour of the end of exposure, especially for those tasks involving:

i) heating of polyurethane

ii) use of:

• HDI (hexamethylene diisocyanate, used in two-pack spray paints)
• TDI (toluene diisocyanate, used in adhesives and foam blowing)

This is recommended as the above-mentioned isocyanates are all rapidly excreted.

End-of-shift testing should be performed with:

i) Encountering abrasion of polyurethane

ii) Exposure to MDI (methyl phenylene diisocyanate)

If significant skin exposure is a possibility, pre-shift next-day samples should also be considered (due to the delayed absorption through the skin).

BM samples mostly reflect that day’s exposure (reflecting the short half-life of excretion), and generally do not illuminate long-term exposure. For this reason, it is recommended that several samples are taken initially to ensure that ‘normal practice’ is captured.

The urine samples should be sent ideally the same day or the next day to Safework Health for analysis. If shipping is delayed, samples should be stored frozen, if possible, prior to despatch.

How do you interpret results?

Interpretation of results requires an appreciation of the work practices, tasks and controls used by an individual worker on the day of sampling.

Results will fit one of three broad categories:

1. No detection — with no evidence of exposure to the requested isocyanates (no further action required and repeat testing in 1 year)
2. Low-level exposure — meaning that exposure was detected but the levels were within the BMGV (control measures and their use should be checked but repeat testing is not required immediately; the result may be due to intermittent behaviours, such a visor-flipping, if the investigation shows no systematic concerns); and
3. Exposure exceeds the BMGV — this requires action be taken to check the control measures and their use and to resample workers once any issues have been resolved (if results remain elevated, further investigation is required but workers do not need to be removed from tasks). Where work practices or exposure controls are significantly altered then retesting should be considered to ensure that exposure levels have not increased as a result.

Safework Health’s NATA accredited isocyanate urine testing service can detect your workers’ exposure to this harmful chemical. We offer a rapid 5-day turnaround for results, an accurate and cost-effective testing method, and national coverage.

Contact our friendly team today to find out how we can keep your workers safe and healthy.

Key features of our biological monitoring service include:

• Rapid Turnaround Time: Time is of the essence in health surveillance schemes. With our commitment to a 5-day turnaround for results, businesses can promptly implement corrective measures, mitigating potential exposures and safeguarding their workers’ health effectively.
• Nationwide Accessibility: We service every state and territory in Australia, ensuring businesses across the country have access to reliable health monitoring solutions. Whether operating in urban centres or remote locations, businesses can now protect their workers’ health regardless of their geographic location.
• NATA Accreditation: Our Brisbane laboratory is at the forefront of excellence in health surveillance. Our chemical testing laboratory is one of the first commercial laboratories in Australia to be awarded NATA accreditation for determining isocyanate and phenol exposure in the workplace. This certification provides assurance that we adhere to the highest standards of quality and accuracy.
• Efficient Testing Method: We use urine testing to assess the level of exposure to hazardous chemicals. Urine testing is a cost-effective and fast way to monitor workers’ health. This approach makes it feasible for businesses of all sizes to implement health monitoring programs.

Employees who work with hazardous chemicals are exposed to potential health risks that may not be immediately evident.

Regular health monitoring is crucially important to detect any potential adverse effects on workers’ health and to ensure their overall well-being is safeguarded.

By adopting a comprehensive health monitoring for exposure to hazardous chemicals scheme, businesses can effectively monitor the health of their workers, enabling them to identify potential exposures early and take preventive measures.

For more information on this ground-breaking new health surveillance testing service, please call us on 1300 795 227 or email us at info@swhealth.com.au